Form 8-K Tonelli retire

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of report (Date of earliest event reported): June 7, 2007

 

IDEXX LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

000-19271

01-0393723

(State or other jurisdiction

(Commission File Number)

(IRS Employer Identification No.)

of incorporation)

 

 

 

 

One IDEXX Drive, Westbrook, Maine

04092

(Address of principal executive offices)

(ZIP Code)

 

207.556.0300

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 7, 2007, Quentin J. Tonelli, PhD announced his intention to retire from the Company effective as of June 30, 2007. Dr. Tonelli has been leading the Company’s production animal segment.

 

 

2

 


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

IDEXX LABORATORIES, INC.

 

 

 

 

 

 

Date: June 12, 2007

By:

/s/ Conan R. Deady

 

 

Conan R. Deady

 

 

Corporate Vice President, General Counsel & Secretary

 

 

 

 

 

 

 

3